Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Suit vs. Forest Labs Names Execs Linked to Alleged Lies About Lexapro, Celexa
- Employees of Forest Labs and that company's rivals should read the U.S. government's complaint against the company, which alleges off-label promotion of Lexapro and Celexa for use in children. The complaint names executives, indicates who knew what and when, and goes into the details of many individual sales reps' actions....
- Blog posts 2009-02-26
- Forest Labs Q1: $170 Million Fee for DOJ; Its Numbers Are Written in "Invisible Ink"
- Forest Labs is holding a $170 million contingency fee in case it needs to settle allegations by the Department of Justice that it bribed doctors --- with such things as $1,000 gift certificates to Alain Ducasse -- into prescribing Lexapro and Celexa for children even though it was not approved...
- Blog posts 2009-04-23
Additional Resources
- Forest Labs' Lexapro Flap Over JAMA Article Will Likely Be Examined by the Feds
- An editor of the Journal of the American Medical Association called a university professor "a nobody and a nothing" after he pointed out, correctly, that a JAMA author had failed to disclose a financial relationship with Forest Labs in an article about Lexapro, according to the WSJ. ...
- Blog posts 2009-03-16
- Forest Labs surprises with strong Celexa sales. (Life Sciences).(Brief Article)(Statistical Data Included)
- FOREST LABORATORIES Inc. surprised on the upside for fiscal second quarter 2003 earnings last week, sent shares of the specialty pharmaceuticals company up $7.84, to $89.85. Forest Labs projects earnings per share EPS to be above the consensus estimate of 57 cents per share by at...
- Research articles 2002-10-07
- Schaeffer's Option Bytes Features Callaway Golf, Forest Labs, Celestica, Best Buy, and Nokia
- CINCINNATI -- Among the stocks featured in the September 15 edition of Schaeffer's Option Bytes are Callaway Golf (NYSE:ELY), Forest Labs (NYSE:FRX), Celestica (NYSE:CLS), Best Buy (NYSE:BBY), and Nokia (NYSE:NOK).
- Research articles 2004-09-15
- Zacks.com Announces that Richard Rhodes Highlights the Following Stocks: eBay, Qualcomm, Amerada Hess Corporation, Forest Labs and Bristol Myers Squibb Company
- CHICAGO -- Richard Rhodes, editor of the Rhodes Report, suggests that hyper to fast growing stocks are on track for a slowdown. Read how recent news from eBay (NASDAQ:EBAY) and Qualcomm (NASDAQ:QCOM) will impact the market, and then read about Amerada Hess Corporation (NYSE:AHC), Forest Labs, Inc. (NYSE:FRX) and Bristol...
- Research articles 2005-01-21
- Zacks.com announces that Richard Rhodes highlights the following stocks: ConAgra, Forest Labs, and Bank of America
- CHICAGO -- Richard Rhodes, editor of The Rhodes Report newsletter, says energy prices have upside risk with the possibility of further violent thrusts. Read about ConAgra (NYSE:CAG), Forest Labs (NYSE:FRX), and Bank of America (NYSE:BAC). Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84
- Research articles 2005-08-30
- Zacks.com Announces That Richard Rhodes Highlights the Following Stocks: Forest Labs, Bank of America, and Weyerhaeuser
- CHICAGO -- Richard Rhodes, editor of The Rhodes Report newsletter, explains that a Fed pause in September is not a 'slam dunk' and he highlights Forest Labs (NYSE:FRX), Bank of America (NYSE:BAC), and Weyerhaeuser (NYSE:WY). Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84
- Research articles 2005-09-13
- Joseph Parnes Recommends the Following Stocks: Andrx, Forest Labs and Valspar
- Business Editors CHICAGO--BUSINESS WIRE--Dec. 27, 2002 Santa Claus may not be coming to Wall Street after all, but investors can still have a happy holiday season by utilizing hedge positions. Market expert Joseph Parnes gives readers the knowledge they need to maintain this position through recommendations on Andrx...
- Research articles 2002-12-27
- Stull, Stull & Brody Announces Class Action against Forest Laboratories, Inc
- NEW YORK -- Notice is hereby given that a class action lawsuit was filed on March 24, 2005 in the United States District Court for the Southern District of New York, against Forest Laboratories, Inc. ("Forest Labs" or the "Company") (NYSE:FRX) on behalf of purchasers of Forest Labs securities between...
- Research articles 2005-03-25
- LOCAL DRUG COMPANY SWALLOWS BITTER PILL: FIRST YEAR OF LOSSES; FOREST LABS FACES FIERCE COMPETITION, DROP IN SALES; ANTIDEPRESSANT MAY HELP.
- In an industry of giants, Forest Laboratories Inc. has always managed to please investors with steady growth, selling pharmaceuticals that the big boys dismissed as too measly. Until this year, that is. While trying to break into the big leagu...
- Research articles 1997-05-26
- Drug revenues give shot in the arm; Antidepressant boosts Forest Labs; analysts want more winners.
- Analysts say they have one word to explain the steady climb in the share price of Forest Laboratories Inc.: Celexa. When the Manhattan-based company first started selling the antidepressant drug in September 1998, its stock was trading at around $40. Analysts say they have one word...
- Research articles 2000-05-29
- Forest Labs gets FDA panel approval for Alzheimer's drug.(News)(Brief Article)
- A FOOD and Drug Administration FDA advisory committee has recommended approval of Forest Laboratories Inc.'s Alzheimer's disease drug Namenda, formerly known as memantine. Although the panel says the effects of the drug are modest, upon final app A FOOD and Drug Administration FDA advisory...
- Research articles 2003-09-29
- Lerach Coughlin Stoia Geller Rudman & Robbins LLP Announces Class Action Suit against Forest Laboratories, Inc
- SAN DIEGO -- Lerach Coughlin Stoia Geller Rudman & Robbins LLP ("Lerach Coughlin") (http://www.lerachlaw.com/cases/forestlabs/) today announced that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Forest Laboratories, Inc. ("Forest Labs") (NYSE:FRX) common stock during...
- Research articles 2005-03-11
- Mack-Cali Leases Over 243,000 Square Feet of Office Space At Jersey City Waterfront Development; SunAmerica, Fidelity and Forest Labs Among Tenants at New Harborside Building
- Business Editors CRANFORD, N.J.--BUSINESS WIRE--August 8, 2001 Mack-Cali Realty Corporation (NYSE: CLI) today announced it has leased over 243,000 square feet of space to four companies at Harborside Financial Center Plaza 5, a new 34-story class A office tower being developed by the Company on the Jersey City,...
- Research articles 2001-08-08
- Forest's Lexapro Ghostwriting Budget Was $100K; Emory on the Payroll
- Forest Labs budgeted $100,000 for ghostwriting articles about its antidepressant Lexapro. The news came in a copy of Forest's 2004 Lexapro marketing plan, unveiled by the Senate’s Special Committee on Aging. by Jim Edwards
- Blog posts 2009-09-03
- Zacks.com Announces That Dr. Edward Olmstead Highlights Options for the Following Stocks: QLogic Corporation, Forest Labs, and AMR Corporation
- CHICAGO -- The beauty of options is the ability to pick up profits in a bearish environment. Dr. Edward Olmstead has a pair of intermediate-term bearish trades and a bonus trade to help you capitalize on a slumping share price. Read about options for QLogic Corp (NASDAQ:QLGC), Forest Laboratories Inc...
- Research articles 2004-06-24
- Zacks Analyst Blog Highlights: ProLogis, Target, Forest Labs and Occidental Petroleum
- CHICAGO -- Zacks.com announces the list of stocks featured in the Broker Upgrades. Every Thursday, Zacks editor Mark Vickery updates the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: ProLogis, Inc. (NYSE: PLD), Target Corporation (NYSE: TGT), Forest Laboratories (NYSE: FRX)...
- Research articles 2007-10-05
- Zacks Analyst Blog Highlights: Wipro Ltd., Robert Half International Inc., Monarch Casino & Resort Inc., Forest Labs, Inc. and Critical Therapeutics Inc
- CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Wipro Ltd. (NYSE: WIT), Robert Half International Inc. (NYSE: RHI), Monarch...
- Research articles 2008-10-27
- Forest Labs: Concerned About Pipeline
- Zacks.com submits: By Jason Napodano, CFA & Brian Marckx, CFA Forest Laboratories, Inc.'s FRX financial results for 2009 were inline with our expectations. EPS fell 3% on revenue growth of 2% as operating cost growth outpaced that of revenue. SG&A expenses grew 10%, reflecting increased costs related to...
- External links 2009-06-18
- << Previous
- page 1 of 1
- Next >>
